Hypertension Induced by Tyrosine-Kinase Inhibitors for the Treatment of Renal Cell Carcinoma in Hemodialysis Patients: A Single-Center Experience and Review of the Literature

Kidney Cancer, Version 3.2015

(2015) Robert J. Motzer et al.   Journal of the National Comprehensive Cancer Network

Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Therapies: A Single Institution Experience

(2014) Aditya V. Shetty et al.   Clinical Genitourinary Cancer

Intradialytic Hypotension and Risk of Cardiovascular Disease

(2014) B. V. Stefansson et al.   Clinical Journal of the American Society of Nephrology

Evidence-Based Clinical Practice Guideline for Renal Cell Carcinoma: The Japanese Urological Association 2011 update

(2012) Tomoaki Fujioka et al.   INTERNATIONAL JOURNAL OF UROLOGY

Clinical Practices and Outcomes in Elderly Hemodialysis Patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2011) B. Canaud et al.   Clinical Journal of the American Society of Nephrology

The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System

(2011) Mariëtte H.W. Kappers et al.   HYPERTENSION

Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress

(2011) Mariëtte H.W. Kappers et al.   HYPERTENSION

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

(2011) B. I. Rini et al.   JNCI-Journal of the National Cancer Institute

Proteinuria and hypertension with tyrosine kinase inhibitors

(2011) Praveen Kandula et al.   KIDNEY INTERNATIONAL

Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis

(2010) V. Ranpura et al.   AMERICAN JOURNAL OF HYPERTENSION

Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors

(2010) Emily S. Robinson et al.   HYPERTENSION

Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels

(2010) Mariëtte H.W. Kappers et al.   HYPERTENSION

Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism

(2009) Agnes Machnik et al.   NATURE MEDICINE

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS

(2009) A. A. Lopes et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The pattern of excess cancer in dialysis and transplantation

(2009) J. H. Stewart et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis

(2008) Xiaolei Zhu et al.   ACTA ONCOLOGICA